Loblaws Pharmaceutical Product Development, North America Division, today announced that Sophia Segal has been Recognized for Excellence in Information Technology Clinical Requirements by Pharmaceutical and Biotechnology executives committee.
Sophia earned top honors in all of the five distinct categories: contribution, knowledge, critical expertise, quality and leadership.
Sophia Segal at the Awards Ceremony.
The results are based on voting responses from both Canada and U.S. from biopharmaceutical industry leader committee responsible for making or influencing decisions to collaborate with contract research organizations (CROs) on clinical development programs.
Leading this committee was Kina Rzayeva, IT Quality Director who has over 20 years international experience in multi-national IT companies in Europe and North America and has held positions of Vice President and Sr. Director.
Company Name: Loblaws Corporation
Contact Person: Kina Rzayeva
Address:1 President\’s Choice Circle
State: ON, L6Y 5S5